Clinical Trials on Hyperparathyroidism, Secondary
Total 1658 results
-
AmgenCompletedChronic Kidney Disease, Secondary HyperparathyroidismBelgium, United States, Germany, Poland, United Kingdom, Lithuania
-
Skane University HospitalKarolinska University HospitalCompletedSecondary Hyperparathyroidism | Disorder Related to Renal Transplantation
-
AmgenRecruitingSecondary HyperparathyroidismSpain, Belgium, Germany, Czechia, Poland, France, Greece, Hungary, Italy, United Kingdom, Lithuania, Portugal
-
Genzyme, a Sanofi CompanyCompletedSecondary HyperparathyroidismUnited States
-
Chinese University of Hong KongCompletedHyperparathyroidism | Arterial StiffnessHong Kong
-
SanofiActive, not recruitingSecondary Hyperparathyroidism-Chronic Kidney DiseaseUnited States, Chile
-
Astellas Pharma IncCompletedSecondary HyperparathyroidismJapan
-
Montefiore Medical CenterTerminatedSecondary Hyperparathyroidism | HypercalcemiaUnited States
-
AbbVie (prior sponsor, Abbott)CompletedModerate to Severe Secondary Hyperparathyroidism | Stage 5 Chronic Kidney Diseases
-
AmgenCompletedSecondary Hyperparathyroidism in Patients With ESRD on HemodialysisUnited States
-
Roxane LaboratoriesCompletedHypocalcemia | Secondary HyperparathyroidismUnited States
-
Penang Hospital, MalaysiaMinistry of Health, MalaysiaCompletedHyperparathyroidism | Kidney DiseaseMalaysia
-
AmgenCompleted
-
KAI PharmaceuticalsCompletedHyperparathyroidism, SecondaryUnited States, Australia
-
OPKO Health, Inc.CompletedVitamin D Insufficiency | CKD Stage 4 | CKD Stage 3 | Secondary Hyperparathyroidism Due to Renal CausesUnited States
-
Hospices Civils de LyonNot yet recruitingHyperparathyroidism, Primary | Hyperparathyroidism, SecondaryFrance
-
OPKO Health, Inc.WithdrawnSecondary Hyperparathyroidism (SHPT) | Stage 5 Chronic Kidney Disease (CKD) | Hemodialysis (HD)
-
Weill Medical College of Cornell UniversityCompletedObesity | Vitamin D Deficiency | Secondary HyperparathyroidismUnited States
-
AmgenCompletedSecondary Hyperparathyroidism | Chronic Renal Insufficiency
-
Chengdu Suncadia Medicine Co., Ltd.Not yet recruiting
-
AbbVie (prior sponsor, Abbott)CompletedEvaluation of Treatment With Zemplar Capsules in the Therapy of Secondary Hyperparathyroidism (SHPT)Chronic Kidney Disease | Secondary HyperparathyroidismBulgaria, Czech Republic, Romania
-
AmgenCompletedChronic Kidney Disease | Secondary Hyperparathyroidism | Kidney Disease
-
University of AarhusCompletedRoux-en-Y Gastric Bypass | Hyperparathyroidism, SecondaryDenmark
-
KAI PharmaceuticalsNucleus Network LtdCompletedHyperparathyroidism, SecondaryAustralia
-
Emory UniversityTerminatedHyperparathyroidism, SecondaryUnited States
-
AmgenCompletedChronic Kidney Disease | Secondary HyperparathyroidismKorea, Republic of, Taiwan, Hong Kong, China, India, Malaysia
-
AmgenCompletedChronic Kidney Disease | Secondary Hyperparathyroidism | Hyperparathyroidism, SecondaryUnited States, Germany, United Kingdom
-
Benha UniversityNew Jeddah Clinic HospitalCompletedDiabetic Nephropathies | Secondary Hyperparathyroidism
-
The University of Hong KongAbbVieUnknownSecondary Hyperparathyroidism | Endstage Renal DiseaseHong Kong
-
AbbottCompletedHemodialysis | Chronic Kidney Disease | Secondary HyperparathyroidismUnited States, Czech Republic, Denmark, Germany, Greece, Italy, Netherlands, Portugal, Russian Federation, Spain, Sweden, United Kingdom
-
ENRICO VERRINAUnknownSecondary HyperparathyroidismItaly
-
AbbottCompletedHemodialysis | Secondary HyperparathyroidismJapan
-
Genzyme, a Sanofi CompanyCompletedRenal Failure | Secondary Hyperparathyroidism | Chronic Renal InsufficiencyUnited States, Puerto Rico
-
AmgenCompletedSecondary HyperparathyroidismUnited States, Italy, Belgium, Switzerland, Hungary, Spain, Turkey, Poland, Portugal, United Kingdom, Czech Republic, Macedonia, The Former Yugoslav Republic of
-
AmgenCompletedEnd Stage Renal Disease | Secondary Hyperparathyroidism
-
AmgenTerminatedHyperparathyroidism | Chronic Kidney Disease | Secondary Hyperparathyroidism | Hyperparathyroidism, Secondary | Kidney DiseaseUnited States, Belgium, Hungary, Spain, Australia, Germany, Poland, Mexico, Russian Federation, Slovakia
-
AmgenCompletedChronic Kidney Disease | Secondary HyperparathyroidismUnited States, Italy, Belgium, Denmark, Switzerland, Canada, Turkey, Spain, Austria, Germany, Hungary, Greece, France, Poland, Russian Federation, Czechia, Latvia, Lithuania, New Zealand, Portugal, Sweden, Estonia
-
AbbVie (prior sponsor, Abbott)CompletedHemodialysis | Secondary HyperparathyroidismJapan
-
AbbottAbbott Japan Co.,LtdCompletedHemodialysis | Secondary HyperparathyroidismJapan
-
OPKO Health, Inc.Active, not recruitingChronic Kidney Diseases | Vitamin D Deficiency | Stage 5 Chronic Kidney Disease | Secondary Hyperparathyroidism Due to Renal CausesUnited States
-
Creighton UniversityGlaxoSmithKlineCompletedOsteoporosis | Secondary Hyperparathyroidism
-
AbbVie (prior sponsor, Abbott)AlmedisCompletedSecondary HyperparathyroidismRussian Federation
-
Atlanta VA Medical CenterEmory UniversityCompletedKidney DiseaseUnited States
-
AbbottCompletedChronic Kidney Disease | Secondary HyperparathyroidismUnited States
-
AbbottCompletedSecondary Hyperparathyroidism | Chronic Kidney FailureGreece
-
Washington University School of MedicineAbbott; NorthShore University HealthSystem; Northwestern University Feinberg... and other collaboratorsCompletedChronic Kidney Disease | Secondary HyperparathyroidismUnited States
-
AmgenCompletedEnd Stage Renal Disease | Secondary Hyperparathyroidism
-
AbbottAbbott Japan Co.,LtdCompletedSecondary Hyperparathyroidism | Chronic Kidney Disease on HemodialysisJapan
-
AmgenCompletedChronic Kidney Disease | Secondary Hyperparathyroidism